RAJAF (Cordyceps Sunshine Biotech Holdings Co) Interest Expense : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cordyceps Sunshine Biotech Holdings Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cordyceps Sunshine Biotech Holdings Co's interest expense for the three months ended in Dec. 2023 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cordyceps Sunshine Biotech Holdings Co's Operating Income for the three months ended in Dec. 2023 was $ 0.12 Mil. Cordyceps Sunshine Biotech Holdings Co's Interest Expense for the three months ended in Dec. 2023 was $ 0.00 Mil. GuruFocus does not calculate Cordyceps Sunshine Biotech Holdings Co's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cordyceps Sunshine Biotech Holdings Co Interest Expense Historical Data

The historical data trend for Cordyceps Sunshine Biotech Holdings Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordyceps Sunshine Biotech Holdings Co Interest Expense Chart

Cordyceps Sunshine Biotech Holdings Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.03

Cordyceps Sunshine Biotech Holdings Co Quarterly Data
	Dec20	Dec21	Dec22	Sep23	Dec23
Interest Expense	-	-	-	-	-

Cordyceps Sunshine Biotech Holdings Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Cordyceps Sunshine Biotech Holdings Co (OTCPK:RAJAF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cordyceps Sunshine Biotech Holdings Co's Interest Expense for the three months ended in Dec. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was $0.12 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $0.57 Mil.

Cordyceps Sunshine Biotech Holdings Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

GuruFocus does not calculate Cordyceps Sunshine Biotech Holdings Co's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Cordyceps Sunshine Biotech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 548, Ruiguang Road, 6th Floor, No. 15, Neihu District, Taipei City, TWN

Website

http://www.cordyceps-sunshine.com

Cordyceps Sunshine Biotech Holdings Co Ltd engages in cultivating Chinese rare medicinal herbs, Cattle camphor mushroom raw materials, and selling its finished products. The company has one business segment: cultivating and sales of Chinese rare medicinal herb, taiwanofungus raw material, and its finished products. The company generates revenue from product sales, training, and related parties.

Cordyceps Sunshine Biotech Holdings Co Headlines

No Headlines